Suppr超能文献

利用国家早期预警评分2(NEWS2)来证实急诊科管理对脓毒症患者的影响:一项来自台湾地区1998 - 2020年的队列研究。

Utilizing the National Early Warning Score 2 (NEWS2) to confirm the impact of emergency department management in sepsis patients: a cohort study from taiwan 1998-2020.

作者信息

Hsieh Ming-Shun, Chiu Kuan-Chih, Chattopadhyay Amrita, Lu Tzu-Pin, Liao Shu-Hui, Chang Chia-Ming, Lee Yi-Chen, Lo Wei-En, Hsieh Vivian Chia-Rong, Hu Sung-Yuan, How Chorng-Kuang

机构信息

Department of Emergency Medicine, Taoyuan Branch, Taipei Veterans General Hospital, Taoyuan, Taiwan.

Department of Emergency Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

出版信息

Int J Emerg Med. 2024 Mar 15;17(1):42. doi: 10.1186/s12245-024-00614-4.

Abstract

BACKGROUND

Most sepsis patients could potentially experience advantageous outcomes from targeted medical intervention, such as fluid resuscitation, antibiotic administration, respiratory support, and nursing care, promptly upon arrival at the emergency department (ED). Several scoring systems have been devised to predict hospital outcomes in sepsis patients, including the Sequential Organ Failure Assessment (SOFA) score. In contrast to prior research, our study introduces the novel approach of utilizing the National Early Warning Score 2 (NEWS2) as a means of assessing treatment efficacy and disease progression during an ED stay for sepsis.

OBJECTIVES

To evaluate the sepsis prognosis and effectiveness of treatment administered during ED admission in reducing overall hospital mortality rates resulting from sepsis, as measured by the NEWS2.

METHODS

The present investigation was conducted at a medical center from 1997 to 2020. The NEWS2 was calculated for patients with sepsis who were admitted to the ED in a consecutive manner. The computation was based on the initial and final parameters that were obtained during their stay in the ED. The alteration in the NEWS2 from the initial to the final measurements was utilized to evaluate the benefit of ED management to the hospital outcome of sepsis. Univariate and multivariate Cox regression analyses were performed, encompassing all clinically significant variables, to evaluate the adjusted hazard ratio (HR) for total hospital mortality in sepsis patients with reduced severity, measured by NEWS2 score difference, with a 95% confidence interval (adjusted HR with 95% CI). The study employed Kaplan-Meier analysis with a Log-rank test to assess variations in overall hospital mortality rates between two groups: the "improvement (reduced NEWS2)" and "non-improvement (no change or increased NEWS2)" groups.

RESULTS

The present investigation recruited a cohort of 11,011 individuals who experienced the first occurrence of sepsis as the primary diagnosis while hospitalized. The mean age of the improvement and non-improvement groups were 69.57 (± 16.19) and 68.82 (± 16.63) years, respectively. The mean SOFA score of the improvement and non-improvement groups were of no remarkable difference, 9.7 (± 3.39) and 9.8 (± 3.38) years, respectively. The total hospital mortality for sepsis was 42.92% (4,727/11,011). Following treatment by the prevailing guidelines at that time, a total of 5,598 out of 11,011 patients (50.88%) demonstrated improvement in the NEWS2, while the remaining 5,403 patients (49.12%) did not. The improvement group had a total hospital mortality rate of 38.51%, while the non-improvement group had a higher rate of 47.58%. The non-improvement group exhibited a lower prevalence of comorbidities such as congestive heart failure, cerebral vascular disease, and renal disease. The non-improvement group exhibited a lower Charlson comorbidity index score [4.73 (± 3.34)] compared to the improvement group [4.82 (± 3.38)] The group that underwent improvement exhibited a comparatively lower incidence of septic shock development in contrast to the non-improvement group (51.13% versus 54.34%, P < 0.001). The improvement group saw a total of 2,150 patients, which represents 38.41% of the overall sample size of 5,598, transition from the higher-risk to the medium-risk category. A total of 2,741 individuals, representing 48.96% of the sample size of 5,598 patients, exhibited a reduction in severity score only without risk category alteration. Out of the 5,403 patients (the non-improvement group) included in the study, 78.57% (4,245) demonstrated no alteration in the NEWS2. Conversely, 21.43% (1,158) of patients exhibited an escalation in severity score. The Cox regression analysis demonstrated that the implementation of interventions aimed at reducing the NEWS2 during a patient's stay in the ED had a significant positive impact on the outcome, as evidenced by the adjusted HRs of 0.889 (95% CI = 0.808, 0.978) and 0.891 (95% CI = 0.810, 0.981), respectively. The results obtained from the Kaplan-Meier analysis indicated that the survival rate of the improvement group was significantly higher than that of the non-improvement group (P < 0.001) in the hospitalization period.

CONCLUSION

The present study demonstrated that 50.88% of sepsis patients obtained improvement in ED, ascertained by means of the NEWS2 scoring system. The practical dynamics of NEWS2 could be utilized to depict such intricacies clearly. The findings also literally supported the importance of ED management in the comprehensive course of sepsis treatment in reducing the total hospital mortality rate.

摘要

背景

大多数脓毒症患者在抵达急诊科(ED)后,若能及时接受针对性的医疗干预,如液体复苏、抗生素使用、呼吸支持及护理,可能会有较好的预后。已经设计了几种评分系统来预测脓毒症患者的医院结局,包括序贯器官衰竭评估(SOFA)评分。与先前的研究不同,我们的研究引入了一种新方法,即利用国家早期预警评分2(NEWS2)来评估脓毒症患者在急诊科住院期间的治疗效果和疾病进展。

目的

通过NEWS2评估脓毒症患者在急诊科入院期间的脓毒症预后及治疗效果,以降低脓毒症导致的总体医院死亡率。

方法

本研究于1997年至2020年在一家医疗中心进行。对连续入住急诊科的脓毒症患者计算NEWS2。计算基于患者在急诊科住院期间获得的初始和最终参数。利用从初始测量到最终测量的NEWS2变化来评估急诊科管理对脓毒症患者医院结局的益处。进行单变量和多变量Cox回归分析,纳入所有具有临床意义的变量,以评估通过NEWS2评分差异衡量的病情严重程度降低的脓毒症患者全因医院死亡率的调整风险比(HR),并给出95%置信区间(调整后的HR及95%CI)。本研究采用Kaplan-Meier分析和对数秩检验来评估两组之间的总体医院死亡率差异:“改善组(NEWS2降低)”和“未改善组(无变化或NEWS2升高)”。

结果

本研究纳入了11011名首次发生脓毒症并作为主要诊断住院的患者队列。改善组和未改善组的平均年龄分别为69.57(±16.19)岁和68.82(±16.63)岁。改善组和未改善组的平均SOFA评分无显著差异,分别为9.7(±3.39)和9.8(±3.38)。脓毒症患者的全因医院死亡率为42.92%(4727/11011)。按照当时的现行指南进行治疗后,11011名患者中有5598名(50.88%)的NEWS2显示有所改善,而其余5403名患者(49.12%)未改善。改善组的全因医院死亡率为38.51%,而未改善组的死亡率更高,为47.58%。未改善组的充血性心力衰竭、脑血管疾病和肾病等合并症患病率较低。未改善组的Charlson合并症指数评分[4.73(±3.34)]低于改善组[4.82(±3.38)]。与未改善组相比,改善组发生感染性休克的发生率相对较低(51.13%对54.34%,P<0.001)。改善组共有2150名患者,占5598名总体样本量的38.41%,从高风险类别转变为中风险类别。共有2741名患者,占5598名患者样本量的48.96%,仅严重程度评分降低但风险类别未改变。在纳入研究的5403名患者(未改善组)中,78.57%(4245名)的NEWS2无变化。相反,21.43%(1158名)的患者严重程度评分升高。Cox回归分析表明,在患者急诊科住院期间实施旨在降低NEWS2的干预措施对结局有显著的积极影响,调整后的HR分别为0.889(95%CI=0.808,0.978)和0.891(95%CI=0.810,0.981)。Kaplan-Meier分析结果表明,在住院期间,改善组的生存率显著高于未改善组(P<0.001)。

结论

本研究表明,50.88%的脓毒症患者在急诊科通过NEWS2评分系统评估获得改善。NEWS2的实际动态变化可以清晰地描绘出这些复杂情况。研究结果还切实支持了急诊科管理在脓毒症综合治疗过程中对于降低全因医院死亡率的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2791/10941441/c9cb2061397c/12245_2024_614_Figa_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验